Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Procurement Quota for Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 250, 12983-12984 [2022-04785]

Agencies

• Department of Justice

[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Pages 12983-12984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04785]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0008]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Procurement Quota for Controlled Substance 
and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 
250

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice, Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget for review and approval in 
accordance with the Paperwork Reduction Act of 1995. This information 
collection is also associated with the proposed rulemaking ``Management 
of Quotas for Controlled Substances and List I Chemicals,'' published 
in the Federal Register. It is likely that the final rule will not be 
published before this information collection expires on June 30, 2022. 
If the final rule does publish prior to the expiration, it will be 
published as the 30-Day Notice.

DATES: Comments are encouraged and will be accepted for 60 days until 
May 9, 2022.

FOR FURTHER INFORMATION CONTACT: If you have comments, especially on 
the estimated public burden or associated response time, suggestions, 
or need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section (DPW), Diversion Control 
Division, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-
2265.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Procurement Quota 
for Controlled Substance and for Ephedrine, Pseudoephedrine, and 
Phenylpropanolamine.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form 250. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): None.
    Abstract: Pursuant to 21 U.S.C. 826 and 21 CFR 1303.12(b) and 
1315.32, any person who desires to use, during the next calendar year, 
any basic class of controlled substances listed in schedules I or II, 
or the List I chemicals ephedrine, pseudoephedrine, or 
phenylpropanolamine for purposes of manufacturing must apply on DEA 
Form 250 for a procurement quota for such class or List I chemical.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
344 respondents complete 3,066 DEA Form 250 applications annually, and 
that each form requires 0.5 hours to complete.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates this collection takes a 
total of 1,533 annual burden hours.
    If additional information is required, please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution

[[Page 12984]]

Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530.

    Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2022-04785 Filed 3-7-22; 8:45 am]
BILLING CODE 4410-09-P